Timelines in the diagnostic evaluation of people with suspected amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) -a 20-year review: Can we do better?

Amyotrophic Lateral Sclerosis

Volumn 11, Issue 6, 2010, Pages 537-541

  Mitchell, John Douglas ^a   Callagher, Pauline ^a   Gardham, Joyce ^a   Mitchell, Catriona ^a   Dixon, Mandy ^a   Addison Jones, Robert ^a   Bennett, Wendy ^a   O'Brien, Mary R ^b  

^a ROYAL PRESTON HOSPITAL   (United Kingdom)

^b EDGE HILL UNIVERSITY   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis; Diagnosis; Diagnostic pathway; Motor neuron disease

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL EVALUATION; DELAYED DIAGNOSIS; DIAGNOSTIC TEST; EARLY DIAGNOSIS; FEMALE; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR NEURON DISEASE; PATIENT REFERRAL; PERFORMANCE; PRIORITY JOURNAL;

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL TRIALS AS TOPIC; GREAT BRITAIN; HUMANS; MOTOR NEURON DISEASE; TIME FACTORS;

EID: 78649288936     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2010.495158     Document Type: Article

References (17)

1. World Federation of Neurology Research Group on Neuromuscular Diseases Subcommittee on Motor Neuron Disease. The El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1994;124(Suppl): 96-107.
2. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. World Federation of Neurology 1998 (http://www.wfnals.org/).
3. Mitchell JD, O'Brien MR, Joshi M. Audit of outcomes in motor neuron disease (MND) patients treated with riluzole. Amyotroph Lateral Scler Other Motor Neuron Disord. 2006;7:67-71.
4. Miller RG, Mitchell JD, Lyon M, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) (Cochrane Review). In: The Cochrane Library, Issue 1, 2007.
5. King SJ, Duke MM, O'Connor BA. People living with ALS/MND tell the diagnosis story: what happened before they knew. Amyotroph Lateral Scler. 2006;7(Suppl 1):34-6.
6. Department of Health. The National Service Framework for long-term conditions. Department of Health (2005).
7. Motor Neurone Disease Association. Standards of care to achieve quality of life for people affected by motor neuron disease (2004).
8. Mitchell JD, O'Brien MR. Centre Report-The MND Care Facility, Preston, UK. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:355-6.
9. Mitchell JD, Houghton E, Rostron G, Wignall C, Gatt JA, Phillips TM, et al. Serial studies of free radical and antioxidant activity in motor neuron disease and the effect of selegiline. Neurodegeneration. 1995;4:233-5.
10. Mitchell JD, Gatrell AC, Al-Hamad A, Davies RB, Batterby G. Geographical epidemiology of residence of patients with motor neuron disease in Lancashire and south Cumbria. J Neurol Neurosurg Psychiat. 1998;65:842-7.
11. Donaghy C, Dick A, Hardiman O, Patterson V. Timeliness of diagnosis in motor neuron disease: a population-based study. Ulster Medical Journal. 2008;77:18-21.
12. Househam E, Swash M. Diagnostic delay in amyotrophic lateral sclerosis: what scope for improvement? Journal of the Neurological Sciences. 2000;180:76-81.
13. O'Brien M, Whitehead B, Mitchell D, Callagher P, Jack B. Descriptive audit of the key characteristics of the current MND population in a large UK specialist MND clinic. Amyotroph Lateral Scler. 2008;9(Suppl 1):147.
14. Callagher P, Mitchell D, Bennett W, Addison-Jones R. Evaluating a fast-track diagnostic service for people suspected of having MND/ALS. British Journal of Neuroscience Nursing. 2009;5:322-5.
15. Belsh JM, Schiffman PL. The amyotrophic lateral sclerosis (ALS) patient perspective on misdiagnosis and its repercussions. Journal of the Neurological Sciences. 1996;139(Suppl): 110-6.
16. Srinivasan J, Scala S, Jones R, Saleh F, Russell J. Inappropriate surgeries resulting from misdiagnosis of early amyotrophic lateral sclerosis. Muscle and Nerve. 2006;34:359-60.
17. MND Association. The Impact of Familial Motor Neuron Disease. Information Sheet, No. P2. 2007. http://tinyurl.com/m2uhv4 (accessed 18 December 2009).